glp-1 for inflammation dosage Microdosing GLP-1: A New Approach to Inflammation-Driven Diseases Compare GLP-1 Options | Ozempic

More than one million Australians have been dispensed a GLP-1 receptor agonist over the past five years, fuelling the emergence []

Adults with obesity and autoimmune disease taking GLP-1 medication experience fewer cardiac events and have a lower risk of death, according to new findings.

The ever-increasing use of GLP-1 agonists is uncovering clues about what else they can do.

Evolving federal policy on popular weight loss medications introduces additional cost and coverage uncertainties.

The once hard-to-get prescription drug is now widely...

Semaglutide can lower blood pressure in some patients while others experience minimal changes